CCNK and lung cancer: As shown in Figure 5D, inhibition of Cyclin K with siRNA significantly reduced basal expression levels of Cyclin D1 and GNG3, while increasing expression levels of PCDH9, WNT9A and GNG7 in two different lung cancer cell lines.